GL1X · GenesisL1 explorer

MolNFT v1 · #116322 · protein

A dimerization-dependent mechanism drives prrsv NSP11 functions as a beta interferon antagonist and endoribonuclease

5DA1: “A dimerization-dependent mechanism drives prrsv NSP11 functions as a beta interferon antagonist and…”. X-ray diffraction, 2 pockets (best druggability 0.47). MolNFT v1 #116322 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
5DA1
Type
protein
Length
427 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endoribonuclease
UniProt
E3V2B6
Pockets
2 · best druggability 0.47

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEndoribonucleaseprotein22216% helix, 37% strandE3V2B6
BEndoribonucleaseprotein20516% helix, 31% strandE3V2B6

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.470.8415empty
2690.300.7418empty

Interfaces

1 interface between chains.

  • A–B · 657 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5DA1 · A Dimerization-Dependent Mechanism Drives PRRSV NSP11 Functions As a Beta Interferon… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.